C. Lindsay DeVane

495 total citations
10 papers, 190 citations indexed

About

C. Lindsay DeVane is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, C. Lindsay DeVane has authored 10 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Psychiatry and Mental health and 2 papers in Molecular Biology. Recurrent topics in C. Lindsay DeVane's work include Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Electroconvulsive Therapy Studies (2 papers). C. Lindsay DeVane is often cited by papers focused on Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Electroconvulsive Therapy Studies (2 papers). C. Lindsay DeVane collaborates with scholars based in United States and China. C. Lindsay DeVane's co-authors include John S. Markowitz, Olga Brawman‐Mintzer, R. Bruce Lydiard, Michael R. Ware, Naresh P. Emmanuel, Gerardo Villarreal, W. Alexander Morton, Gary M. Levin, Stanley W. Carson and Aaron Liston and has published in prestigious journals such as Annals of Pharmacotherapy, International Clinical Psychopharmacology and PubMed.

In The Last Decade

C. Lindsay DeVane

8 papers receiving 178 citations

Peers

C. Lindsay DeVane

PMH

PHARM

PPCH

ECP

Peggy E. Hayes United States

I. Zieleniuk France

Joseph R. Magliozzi United States

Thea Moore United States

Michaela Strobelberger United States

Frederik Vandenberghe Switzerland

Kai‐Ming Duan China

Dominique Warot France

Helene Støle Melsom Norway

Ann L. Richards United States

Peggy E. Hayes United States

C. Lindsay DeVane

64 ×1.0

PMH

65 ×1.2

PHARM

27 ×0.7

PHARM

21 ×0.8

PPCH

52 ×2.0

ECP

Citations per year, relative to C. Lindsay DeVane C. Lindsay DeVane (= 1×) peers Peggy E. Hayes

Countries citing papers authored by C. Lindsay DeVane

Since Specialization

Citations

This map shows the geographic impact of C. Lindsay DeVane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lindsay DeVane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lindsay DeVane more than expected).

Fields of papers citing papers by C. Lindsay DeVane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lindsay DeVane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lindsay DeVane. The network helps show where C. Lindsay DeVane may publish in the future.

Co-authorship network of co-authors of C. Lindsay DeVane

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lindsay DeVane. A scholar is included among the top collaborators of C. Lindsay DeVane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lindsay DeVane. C. Lindsay DeVane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

DeVane, C. Lindsay, et al.. (2025). An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology. Psychopharmacology Bulletin. 35(1). 42–52. 2 indexed citations

2.

DeVane, C. Lindsay & C. Lindsay DeVane. (2025). Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions. Psychopharmacology Bulletin. 36(3). 5–21. 1 indexed citations

3.

DeVane, C. Lindsay, et al.. (2025). Psychoactive Drug Interactions With Pharmacotherapy for Diabetes. Psychopharmacology Bulletin. 36(2). 40–50.

4.

Levin, Gary M., Leigh Anne Nelson, Sandra L. Preston, et al.. (2025). A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir. Psychopharmacology Bulletin. 35(2). 62–71.

5.

DeVane, C. Lindsay & Stanley W. Carson. (2015). Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR. Psychopharmacology Bulletin. 37(Suppl. 1). 29–40. 3 indexed citations

6.

DeVane, C. Lindsay & John S. Markowitz. (2000). Avoiding psychotropic drug interactions in the cardiovascular patient.. PubMed. 64(1). 49–59. 11 indexed citations

7.

DeVane, C. Lindsay, Michael R. Ware, Naresh P. Emmanuel, et al.. (1999). Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. International Clinical Psychopharmacology. 14(6). 345–351. 32 indexed citations

8.

DeVane, C. Lindsay. (1998). Differential pharmacology of newer antidepressants.. PubMed. 59 Suppl 20. 85–93. 65 indexed citations

9.

DeVane, C. Lindsay. (1994). Pharmacogenetics and drug metabolism of newer antidepressant agents.. PubMed. 55 Suppl. 38–45; discussion 46. 71 indexed citations

10.

Levin, Gary M. & C. Lindsay DeVane. (1993). Prescribing Attitudes of Different Physician Groups regarding Fluoxetine. Annals of Pharmacotherapy. 27(12). 1443–1447. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact